Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis

Abstract : Protein kinases (PKs) are one of the largest protein families in most eukaryotic organisms. These enzymes are involved in the control of cell proliferation, differentiation and metabolism and a large number of the anticancer drugs currently used are directed against PKs. The structure and function of PKs are well conserved throughout evolution. In schistosome parasites, PKs were shown to be involved in essential functions at every stage of the parasite life cycle, making these enzymes promising anti-parasite drug targets. In this study, we tested a panel of commercial inhibitors for various PKs and analyzed their effects on pairing and egg production by schistosomes as well as their toxicity towards schistosomula larvae. Results obtained confirmed the deleterious effect of PK targeting on Schistosoma mansoni physiology and the important function of different tyrosine and serine/threonine kinases in the biology and reproduction of this parasite. They also indicated for the first time that the Protein kinase B (also called Akt) which is a major downstream target of many receptor tyrosine kinases and a central player at the crossroads of signal transduction pathways activated in response to growth factors and insulin, can constitute a novel target for anti-schistosome chemotherapy. Structural and functional studies have shown that SmAkt is a conserved kinase and that its activity can be inhibited by commercially available Akt inhibitors. In treated adult worms, Akt/PKB kinase pathway inhibitors induced profound alterations in pairing and egg laying and they also greatly affected the viability of schistosomula larvae.
Liste complète des métadonnées

https://hal.univ-lille.fr/hal-03200280
Contributeur : Lilloa Université de Lille Connectez-vous pour contacter le contributeur
Soumis le : vendredi 16 avril 2021 - 13:33:11
Dernière modification le : mardi 19 octobre 2021 - 23:56:32
Archivage à long terme le : : samedi 17 juillet 2021 - 18:41:53

Fichier

1-s2.0-S221132071400027X-main....
Fichiers éditeurs autorisés sur une archive ouverte

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale - Pas de modification 4.0 International License

Identifiants

Collections

Citation

Marion Morel, Mathieu Vanderstraete, Katia Cailliau-Maggio, Arlette Lescuyer, Julien Lancelot, et al.. Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis. International journal for parasitology. Drugs and drug resistance, Elsevier, 2014, 4 (3), pp.256-266. ⟨10.1016/j.ijpddr.2014.09.004⟩. ⟨hal-03200280⟩

Partager

Métriques

Consultations de la notice

37

Téléchargements de fichiers

66